NCT04502550View on ClinicalTrials.gov

Brain Networks and Consciousness

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

November 14, 2024

Study Completion Date

November 14, 2024

Conditions
Loss of ConsciousnessParkinson DiseaseEssential TremorAnesthesia
Interventions
DRUG

Propofol

Target effect-site concentration of propofol will be started at 1.4 μg/mL and will be increased by 0.3 μg/mL with reassessment until endpoints are achieved.

Trial Locations (1)

75235

Nader Pouratian, Dallas

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT04502550 - Brain Networks and Consciousness | Biotech Hunter | Biotech Hunter